A tetracycline-repressible transactivator approach suggests a shorter half-life for tyrosine hydroxylase mRNA

Brain Research Protocols

Volumn 7, Issue 2, 2001, Pages 137-146

  Foster, David ^a   Strong, Randy ^a,b   Morgan, William W ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Education   (United States)

Author keywords

Catecholamines; mRNA stability; Post transcriptional regulation; Tyrosine hydroxylase; Tyrosine hydroxylase gene

Indexed keywords

DACTINOMYCIN; DOXYCYCLINE; MESSENGER RNA; TETRACYCLINE; TRANSACTIVATOR PROTEIN; TYROSINE 3 MONOOXYGENASE;

ARTICLE; GENE EXPRESSION REGULATION; HALF LIFE TIME; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANTI-BACTERIAL AGENTS; DACTINOMYCIN; DOXYCYCLINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR BIOLOGY; NEUROBLASTOMA; NUCLEIC ACID SYNTHESIS INHIBITORS; RECOMBINANT FUSION PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE;

EID: 0035033953     PISSN: 1385299X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1385-299X(01)00056-3     Document Type: Article

References (35)

1. Axelrod J., Reisine T. Stress hormones: their interaction and regulation. Science. 224:1984;452-459.
2. Chen F., MacDonald C.C., Wilusz J. Cleavage site determinants in the mammalian polyadenylation signal. Nucleic Acids Res. 23:1995;2614-2620.
3. Corbitt J., Vivekananda J., Wang S.S., Strong R. Transcriptional and posttranscriptional control of tyrosine hydroxylase gene expression during persistent stimulation of pituitary adenylate cyclase-activating polypeptide receptors on PC12 cells: regulation by protein kinase A-dependent and protein kinase A-independent pathways. J. Neurochem. 71:1998;478-486.
4. Czyzyk-Krzeska M.F., Beresh J.E. Characterization of the hypoxia-inducible protein binding site within the pyrimidine-rich tract in the 3′-untranslated region of the tyrosine hydroxylase mRNA. J. Biol. Chem. 271:1996;3293-3299.
5. Czyzyk-Krzeska M.F., Dominski Z., Kole R., Millhorn D.E. Hypoxia stimulates binding of a cytoplasmic protein to a pyrimidine-rich sequence in the 3′ untranslated region of rat tyrosine hydroxylase mRNA. J. Biol. Chem. 269:1994;9940-9945.
6. Czyzyk-Krzeska M.F., Furnari B.A., Lawson E.E., Milhorn D.E. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem. 269:1994;760-764.
7. Fossum L.H., Sterling C.R., Tank A.W. Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid. Mol. Pharmacol. 42:1992;898-908.
8. Gossen M., Bonin A.L., Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem. Sci. 18:1993;471-475.
9. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
10. Haycock J.W., Meligeni J.A., Bennet W.F. Phosphorylation and activation of tyrosine hydroxylase mediate the acetylcholine-induced increase in catecholamine biosynthesis in adrenal chromaffin cells. J. Biol. Chem. 257:1982;12641-12648.
11. Jain V., Magrath I. A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: Application to quantitation of β-galactosidase in lacZ-transfected cells. Anal. Biochem. 199:1991;119-124.
12. Kedzierski W., Aguila-Mansilla N., Kozlowski G.P., Porter J.C. Expression of tyrosine hydroxylase gene in cultured hypothalamic cells: roles of protein kinase A and C. J. Neurochem. 62:1994;431-437.
13. Kessler O., Chasin L.A. Effects of nonsense mutations on nuclear and cytoplasmic adenine phosphoribosyltransferase RNA. Mol. Cell. Biol. 16:1996;4426-4435.
14. Knutsen H.K., Tasken K.A., Eskild W., Jahnsen R., Hansson V. Adenosine 3′,5′-monophosphate-dependent stabilization of messenger ribonucleic acids (mRNAs) for protein kinase-A (PKA) subunits in rat Sertoli cells: rapid degradation of mRNAs for PKA subunits is dependent on ongoing RNA and protein synthesis. Endocrinology. 129:1991;2496-2502.
15. Lupton S.D., Brunton L.L., Kalberg V.A., Overell R.W. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:1991;3374-3378.
16. Maurer J.A., Wray S. Neuronal dopamine subpopulations maintained in hypothalamic slice explant culture exhibit distinct tyrosine hydroxylase mRNA turnover rates. J. Neurosci. 17:1997;4552-4561.
17. Morgenroth J.H.I., Hegstrand L.R., Roth R.H., Greengard P. Evidence for involvement of protein kinase in the activation by adenosine 3′:5′ monophosphate of brain tyrosine 3-monoxygenase. J. Biol. Chem. 250:1975;1946-1948.
18. Nagatsu T., Levitt M., Udenfriend S. Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis. J. Biol. Chem. 239:1964;2910-2917.
19. O'Malley K.L. Sequence homology between tyrosine hydroxylase mRNA and a rat adrenal medullary cDNA. J. Neurosci. Res. 16:1986;3-12.
20. Paulding W.R., Czyzyk-Krzeska M.F. Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3′-untranslated region. J. Biol. Chem. 274:1999;2532-2538.
21. Ree A.H., Knutsen H.K., Landmark B.F., Eskild W., Hansson V. Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule? Endocrinology. 131:1992;1810-1814.
22. Reich E., Goldberg I.H., Rabinowitz M. Structure-activity correlations of actinomycins and their derivatives. Nature. 196:1962;743-748.
23. Revel M., Hiatt H.H., Revel J. Actinomycin D: An effect on rat liver homogenates unrelated to its action on RNA synthesis. Science. 146:1964;1311-1313.
24. Ross R.A., Biedler J.L., Spengler B.A., Reis D.J. Neurotransmitter-synthesizing enzymes in 14 human neuroblastoma cell lines. Cell. Mol. Neurobiol. 1:(3):1981;301-311.
25. Ross R.A., Joh T.H., Reis D.J., Spengler B.A., Biedler J.L. Neurotransmitter-synthesizing enzymes in human neuroblastoma cells: relationship to morphological diversity. Evans A.E. Advances in Neuroblastoma Research, Progress in Cancer Research and Therapy. Vol. 12:1980;151-160 Raven Press, New York.
26. Sawicki S.G., Godman G.C. On the differential cytotoxicity of actinomycin D. J. Cell Biol. 50:1971;746-761.
27. Singer R.H., Penman S. Stability of HeLa cell mRNA in actinomycin. Nature. 240:1972;100-102.
28. Soeiro R., Amos H. mRNA half life measured by use of actinomycin D in animals cells - a caution. Biochim. Biophys. Acta. 129:1966;406-409.
29. Sokal R.R., Rohlf F.J. Biometry. 1995;W.H. Freeman, New York. pp. 1-887.
30. Stacey K.J., Nagamine Y., Hume D.A. RNA synthesis inhibition stabilises urokinase mRNA in macrophages. FEBS Lett. 356:1994;311-313.
31. Tanaka M., Herr W. Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation. Cell. 60:1990;375-386.
32. Vyas S., Biguet N.F., Mallet J. Transcriptional and post-transcriptional regulation of tyrosine hydroxylase by protein kinase C. EMBO J. 9:1990;3707-3712.
33. Wahle E. 3′-end cleavage and polyadenylation of mRNA precursors. Biochim. Biophys. Acta. 1261:1995;183-194.
34. Weiner N. Regulation of norepinephrine biosynthesis. Annu. Rev. Pharmacol. Toxicol. 10:1970;273-290.
35. Zivkovic B., Guidotti A., Costa E. Effects of neuroleptics on striatal tyrosine hydroxylase: Changes in affinity for the pteridine cofactor. Mol. Pharmacol. 10:1974;727-735.